domingo, 27 de agosto de 2017

IVF competition forces prices down in Australia

IVF competition forces prices down in Australia



IVF competition forces prices down in Australia
     
Australian IVF companies are experiencing slow growth despite having lowered the price of basic fertility treatments.
Two of Australia’s biggest IVF providers, Virtus and Monash IVF, this week reported sluggish annual growth. Virtus’ annual profit slumped 15 per cent to $28.1 million in the 2016/17 financial year, while Monash IVF managed only a very modest net profit increase.
Monash and Virtus recently introduced low cost treatments to match the budget services offered by new provider Primary Health Care.
Low cost Virtus clinics now offer cycles for out-of-pocket costs of between $900 and $1,500, compared with premium service facilities that charge around $5,000.
Virtus CEO Sue Channon attributed the lacklustre growth to a slump in domestic demand, but said that growth would pick up in coming years.
"We have seen fairly significant growth in single women and same sex couples accessing our donor services," Ms Channon told AAP.
"Annual growth rate variability is not unusual and historically we see that following periods of lower activity we see improvement, and that's due to the pent up demand."
Ms Channon said genetic screening was a key area of growth for Virtus, with revenue from pre-implantation genetic diagnosis and screening increasing by more than one third in 2016/17.
"We can expect to see growth ... in genetic screening, we have expended our testing platform and we'll be doing serology and early obstetrics pathology testing," she said.




Bioedge

Saturday, August 26, 2017

One unfortunate consequence of the omphalocentric state of American politics is that cries for help from the rest of the world are a mosquito’s buzz in a theatre full of bellowing politicians. President Trump’s antics suck all the air out of media interest in overseas tragedies.

One of these, as reported below, is a cholera epidemic in Yemen which has affected half a million people and killed about 2,000. The medical system in this country of 27 million has all but collapsed. About 10,000 civilians have died. Seven million are close to famine.

The United Nations has described Yemen as “the world’s largest humanitarian crisis” and The Lancet has compared Western indifference to its slowness in responding to the Rwandan genocide.

Notwithstanding his “America first” policy, Donald Trump promised that his country would “continue and continue forever to play the role of peacemaker”. Of course, the war in Yemen is a complex conflict in which the two sides are proxies for the Shia state of Iran and the Sunni kingdom of Saudi Arabia. But surely the US could help engineer a solution – if its president was not so busy arguing over Civil War statues and sacking his closest aides.

 
Michael Cook
Editor
BioEdge
 Comment on BioedgeFind Us on FacebookFollow us on Twitter
NEWS THIS WEEK
 
by Michael Cook | Aug 26, 2017
Hundreds of thousands are sick with cholera in the middle of a civil war
 
by Michael Cook | Aug 26, 2017
Some IVF clinics are offering a radical technique for older women
 
by Xavier Symons | Aug 26, 2017
Australian IVF companies are experiencing slow growth despite having lowered prices.
 
by Xavier Symons | Aug 26, 2017
At least three Victorian doctors are under investigation for granting unwarranted vaccination exemptions.
 
by Michael Cook | Aug 26, 2017
Bioethics, the ethics of life, has bifurcated into medical ethics and environmental ethics. Can we reunite them?
 
by Michael Cook | Aug 26, 2017
... not long after a triple suicide inspired by Exit International, his organisation
BioEdge
Suite 12A, Level 2 | 5 George St | North Strathfield NSW 2137 | Australia
Phone: +61 2 8005 8605
Mobile: 0422-691-615
IVF competition forces prices down in Australia

No hay comentarios:

Publicar un comentario